Commonwealth of Pennsylvania Public School Employees Retirement System’s AbCellera Biologics ABCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-21,664
Closed -$63.5K 1621
2024
Q4
$63.5K Buy
+21,664
New +$60.3K ﹤0.01% 1601
2024
Q3
Sell
-250,248
Closed -$741K 1586
2024
Q2
$741K Hold
250,248
﹤0.01% 1031
2024
Q1
$1.13M Hold
250,248
0.01% 875
2023
Q4
$1.43M Hold
250,248
0.01% 768
2023
Q3
$1.15M Hold
250,248
0.01% 976
2023
Q2
$1.62M Hold
250,248
0.01% 1145
2023
Q1
$1.89M Hold
250,248
0.02% 950
2022
Q4
$2.54M Buy
+250,248
New +$2.89M 0.02% 678

Other funds holding ABCL

Commonwealth of Pennsylvania Public School Employees Retirement System's ABCL Position: Q1 2025 in Review

Commonwealth of Pennsylvania Public School Employees Retirement System sold out of AbCellera Biologics (ABCL) in Q1 2025, closing a stake of 21,664 shares — an estimated $63.5K sold.

Commonwealth of Pennsylvania Public School Employees Retirement System first reported a position in ABCL in Q4 2022 and held it in 8 quarters. The position peaked at $2.54M in Q4 2022. 129 funds tracked by Wall St. Rank hold ABCL as of Q1 2025.

  • Commonwealth of Pennsylvania Public School Employees Retirement System reported no remaining AbCellera Biologics position as of Q1 2025 after selling out during the quarter.
  • Commonwealth of Pennsylvania Public School Employees Retirement System sold 21,664 AbCellera Biologics shares in Q1 2025, an estimated $63.5K.
  • Commonwealth of Pennsylvania Public School Employees Retirement System first reported a position in AbCellera Biologics in Q4 2022 and held it in 8 quarters.
  • Commonwealth of Pennsylvania Public School Employees Retirement System's AbCellera Biologics position peaked at $2.54M in Q4 2022.
  • 129 funds tracked by Wall St. Rank held AbCellera Biologics as of Q1 2025.

Based on Commonwealth of Pennsylvania Public School Employees Retirement System's 13F filing for Q1 2025, filed 13 May 2025.